Drug Enforcement Administration April 2013 – Federal Register Recent Federal Regulation Documents

Importer of Controlled Substances, Notice of Application, Lipomed
Document Number: 2013-09538
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances: Notice of Registration; Fisher Clinical Services, Inc.
Document Number: 2013-09537
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Wildlife Laboratories, Inc.
Document Number: 2013-09535
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Research Triangle Institute
Document Number: 2013-09533
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; S & B Pharma Inc.
Document Number: 2013-09532
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc.
Document Number: 2013-09531
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Cayman Chemical Company
Document Number: 2013-09530
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; PCAS-Nanosyn, LLC
Document Number: 2013-09529
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Navinta, LLC
Document Number: 2013-09318
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Penick Corporaton
Document Number: 2013-09317
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, American Radiolabeled Chemicals, Inc.
Document Number: 2013-09315
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Rhodes Technologies
Document Number: 2013-09305
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Almac Clinical Services, Inc., (ACSI)
Document Number: 2013-09302
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2013-09299
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Catalent CTS., Inc.
Document Number: 2013-09293
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; GE Healthcare
Document Number: 2013-09290
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Rhodes Technologies
Document Number: 2013-09283
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Methylone Into Schedule I
Document Number: 2013-08673
Type: Rule
Date: 2013-04-12
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance 3,4- methylenedioxy-N-methylcathinone (methylone) including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule I of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Document Number: 2013-08671
Type: Proposed Rule
Date: 2013-04-12
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule three synthetic cannabinoids into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 1-pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone (UR-144), 1-(5-fluoro-pentyl)-1H- indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144; XLR11) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will be published in the Federal Register and may not be issued prior to May 13, 2013. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls of Schedule I substances under the CSA on the manufacture, distribution, possession, importation, and exportation of these synthetic cannabinoids.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.